Shanghai Rightongene Biotechnology Co., Ltd. (SHA:688217)
23.49
+0.28 (1.21%)
At close: Jun 12, 2026
-3.61% (1Y)
| Market Cap | 1.30B +0.5% |
| Revenue (ttm) | 162.81M -28.7% |
| Net Income | -58.72M |
| EPS | -1.06 |
| Shares Out | 55.19M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | 0.34 (1.45%) |
| Ex-Dividend Date | n/a |
| Volume | 1,179,242 |
| Open | 23.21 |
| Previous Close | 23.21 |
| Day's Range | 22.76 - 23.90 |
| 52-Week Range | 22.68 - 36.00 |
| Beta | 0.33 |
| Analysts | Strong Buy |
| Price Target | n/a |
| Earnings Date | Aug 28, 2026 |